Comprehensive analysis and experimental validation of disulfidptosis-associated prognostic signature and immune microenvironment characterization of gastric cancer. Zhang, Huangjie (H);Hu, Jinguo (J);Li, Yuanqiang (Y);Liu, Yanyang (Y);Shen, Huize (H);Wang, Zeng (Z);Li, Qinglin (Q); |
Author information Cancer Immunol Immunother.2025 Feb 25;74(4):116.doi:10.1007/s00262-024-03883-3 Abstract BACKGROUND: Gastric cancer (GC) is one of the most common causes of cancer-related death worldwide. As a novel form of programmed cell death, disulfidptosis is characterized by excessive cysteine accumulation, disulfide stress and actin destruction. There is evidence that targeting disulfidptosis is a promising anticancer strategy. Further improvement of GC risk stratification based on disulfidptosis has positive clinical significance. |
© Copyright 2013-2025 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only.
Use of this website is governed by the GIHF terms of use and privacy statement.